Register for IPO Updates
US IPO Stats
IPO Industry Breakdown
Largest Global IPOs
Largest US IPOs
IPO News Archive
New Ways to Invest in IPOs - IPO ETFs
US IPO Week Ahead: Six IPOs cap off a busy May as US Foods seeks $1 billion
Analyst IPO Market Commentary
The year's most active week by deal count and proceeds is set to cap off the
year's busiest month
six scheduled IPOs
would bring May's IPO count up to 16, making it the busiest month since October 2015.
There were no IPOs of LBO'd companies in the 1Q16, but three have been completed so far in the 2Q (+20% avg. return), and
three more are set to price
, including a $1 billion offering from US Foods. We expect IPO investors to continue to make valuations a sticking point for these highly-levered deals in order to guarantee a healthy return for their risk.
Food Fight: US Foods to raise $1 billion
US Foods Holding
) aims to raise $1 billion in the largest US IPO of an LBO since KKR's last deal, First Data (
; -29%), in October 2015. It is the largest IPO by sales ($23 billion) since October 2013. The second-largest US foodservice distributor will undoubtedly be compared to key public peers Sysco (#1) and October 2015 IPO Performance Food Group (
; #3; +26%). Both stocks had made uninterrupted gains in 2016 until last Monday, but a recent slide could pressure US Foods' proposed valuation. US Foods boasts strong margins and free cash flow, which it will need to pay down its massive debt load as the company attempts to improve organic growth.
Hospital better have my money: Helping insurers pay the right amount or get it back
) is notable for its strong growth and adjusted EBITDA margins, with over $550 million in sales. The company was formed in 2014 when PE backer Advent International combined Connolly Consulting (audits paid medical claims) with iHealth Technologies (audits filed medical claims). While Cotiviti has signed on most of the nation's top health plans, customer concentration is a key risk in the notoriously uncertain US healthcare industry. It will need to continue to improve free cash flow as it pays down post-IPO debt. It plans to raise $225 million, just 13% of its proposed market cap.
GMS brings wall-to-wall IPO action
Gypsum Supply and Management
) is the industry's leading distributor of wallboard with a 13% market share. LBO'd by AEA Investors in 2014, GMS has grown through acquisitions and the rebounding US construction market, similar to LBO'd landscape supplies distributor SiteOne (
; +38%), which went public earlier this month. The company plans to raise $154 million to pay down debt.
Midland States Bancorp
), which has nearly $3 billion in assets and 46 bank branches in and around Illinois, hopes to continue its acquisition-driven expansion by raising $89 million (reduced from $101 million). The bank postponed an IPO in 2011, and since then has entered mortgage origination and wealth management in new areas.
Two small health care deals with big insider buying
) hopes to raise $60 million (75% insider buying) at a market cap of $300 million. The biotech raised $1 billion from AbbVie before its lead candidate failed a Phase 3 trial in 2013, but Reata believes that same candidate can be used to treat a new indication, pulmonary hypertension, based on positive Phase 2 results.
), targets a $60 million IPO (42% insider buying) at a $260 million market cap. Backed by Hatteras Ventures, Clearside is developing formulations of approved therapies for the eye disease macular edema, a highly competitive space, delivered through its proprietary device.
), a blank check company formed by the CEOs of Landry's and Jefferies, is set to price its large $300 million offering in the week ahead. SPACs are not included in our IPO stats.
Cancer Prevention Pharmaceuticals
), a micro-cap biotech, could price its IPO in the week ahead after it lowered the deal size on Friday by 35% to $16 million ($99 million market cap).
Renaissance Capital's IPO Calendar - Week of 5/23/2016
Top 2 bookrunners
US Foods Holding
$21 - $24
Second-largest US foodservice distributor LBO'd by KKR and CD&R.
$17 - $19
Provides analytics-driven payment accuracy solutions mainly to healthcare clients.
Gypsum Management and Supply
$21 - $23
Leading North American distributor of wallboard and ceiling systems.
Midland States Bancorp
$22 - $24
Keefe Bruyette Woods
Midwestern bank with 81 locations and $2.9 billion in assets.
$14 - $16
Cowen & Co
Developing therapies for life-threatening forms of pulmonary hypertension.
$14 - $16
Cowen & Co
Developing a combination drug-device therapy for eye diseases.
Institutional investors rely on Renaissance Capital's
for these IPOs.
Follow us on Twitter (
) for IPO news as it happens and
register for our updates
on the IPO market.
IPO Market Snapshot
The Renaissance IPO Indices are market cap weighted baskets of newly public companies. The Renaissance IPO Index is down 6% year-to-date, while the Nasdaq is down 5% (S&P flat). Renaissance Capital's
(NYSE: IPO) tracks the index, and
top ETF holdings
include Alibaba (
), Synchrony Financial (
) and Citizens Financial Group (
). The Renaissance International IPO Index is down 4% year-to-date, compared to -1% for ACWX. Renaissance Capital’s International
(NYSE: IPOS) tracks the index, and
top ETF holdings
include NN Group and Aena S.A.
To find out if this is the best ETF for you, visit our
IPO Investing page
Keywords / Tickers:
Recently Priced IPOs
ETF Express Award:
ETFExpress awards are based on a 'peer review system' whereby readers - including institutional and high net worth investors as well as managers and other industry professionals at fund administrators, brokers, custodians and advisers - are invited to elect a 'best in class' in a series of categories via an online survey. In each category, the firms with the most votes at the end of the voting period are subject to a final review by ETFExpress's Senior Editorial team.
Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than the original cost. Investors should consider the investment objectives, risks, charges and expenses carefully before investing.
As stated in the Prospectus, the total annual operating expenses for the Fund was 3.48%. The Adviser has contractually agreed to keep net expenses from exceeding 2.50% of the Fund's average daily net assets for at least a year from the date of the Prospectus and for an indefinite period thereafter subject to annual re-approval of the agreement by the Board of Trustees.
An investor cannot invest directly in an index. Index returns do not represent Fund returns. The Index does not charge management fees or brokerage expenses, nor does the Index lend securities, and no revenues from securities lending were added to the performance shown.
Definitions: Net Asset Value (NAV) of the fund is calculated by dividing the total value of all the securities in its portfolio, less any liabilities, by the number of fund shares outstanding. Market Price is current value at which an asset or service can be bought or sold. Premium/Discount is provided to show the comparison of the daily net asset value (NAV) and the midpoint of the closing bid/ask for each of the funds.
Renaissance IPO Index® (IPOUSA)
is a stock market index based upon a portfolio of U.S.-listed newly public companies that includes securities prior to their inclusion in core U.S. equity portfolios.
Renaissance International IPO Index® (IPOXUS)
is a stock market index based upon a portfolio of newly public companies listed on non-U.S. exchanges.
The S&P 500® Index (SPX) is a stock market index which includes 500 U.S. listed companies and seeks to capture approximately 80% coverage of available U.S. market capitalization.
Risk Disclosure: Investments in the
Renaissance IPO ETF, symbol "IPO"
Renaissance International IPO ETF, symbol "IPOS"
(the "ETFs"), and the
Global IPO Fund, symbol "IPOSX"
(the "Mutual Fund") are subject to investment risk, including possible loss of the principal amounts invested. The ETFs and the Mutual Fund (the "Funds") invest in companies that have recently completed initial public offerings. These stocks are unseasoned equities lacking trading history, a track record of reporting to investors and widely available research coverage which many result in extreme price volatility. Due to a greater number of IPOs in certain segments, the Funds may also be subject to information technology and financial sector risk, small and mid-capitalization company risk, and, for the Renaissance International IPO ETF, emerging markets risk. The Funds may hold securities in the form of Depository Receipts, REITs, and Partnership Units which have greater risks than common shares. The strategies have high portfolio turnover and securities lending risks. The returns of the ETFs may not match the return of the respective indices. The ETFs are classified as non-diversified investment companies subject to concentration risk.
Prospectus: Investors should consider the investment objectives, risks, charges and expenses carefully before investing. For a prospectus and/or summary prospectus with this and other information, please visit
. Read the prospectus carefully before investing. Renaissance Capital Investments, Inc., distributor for the Mutual Fund. Foreside Fund Services, LLC, distributor for the ETFs, 1-866-486-6645.
Definitions: The Renaissance IPO Index® is a stock market index based upon a portfolio of U.S.-listed newly public companies that includes securities prior to their inclusion in core U.S. equity portfolios. The S&P 500® Index is a stock market index based on the market capitalizations of 500 large companies whose common stock is publicly traded on the NYSE or Nasdaq.
The information contained herein is proprietary and copyrighted. The media is welcome to use our information and ideas, provided that the following sourcing is included: Renaissance Capital - manager of IPO-focused ETFs.
The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Renaissance IPO ETF (symbol: IPO), the Renaissance International IPO ETF (symbol: IPOS), or the Global IPO Fund (symbol: IPOSX), may have investments in securities of companies mentioned.
Register for Updates
Renaissance Capital LLC is an SEC-registered investment adviser.
Renaissance Capital Investments, Inc. is a
-registered broker-dealer, and member of
© 2016 Renaissance Capital LLC. All rights reserved.